CSR

INDONESIA UNITED AGAINST COVID-19 KALBE AND PUSKESAD IN COLLABORATION

INDONESIA UNITED AGAINST COVID-19 KALBE AND PUSKESAD IN COLLABORATION

Jakarta, January 10, 2022. PT Kalbe Farma Tbk (Kalbe) partnered with the Army Health Center (PUSKESAD) to collaborate against COVID-19 on the theme "Together we maintain Indonesian immunity, Indonesia United Against COVID-19". Starting the year 2022, the Omicron variant of COVID-19 in Indonesia has increased and therefore immunity in the body needs to be increased to maintain the integrity of all body mechanisms against dangers, both those originating from outside the body and from within the body itself. For this reason, in this activity, Kalbe conducted health education for young doctors, TNI AD officers at PUSKESAD, who are also the guards for handling COVID-19, and extending the information to the public by giving an explanation about "The Role of Doctors in Improving Public Immunity"  that is delivered by dr. Ulul Albab, Sp.OG from the Indonesian Doctors Association (IDI) and "Optimal Body Endurance Amid Uncertainty" by dr. Helmin Silalahi, Medical Senior Manager of Kalbe Consumer Health with the material... This activity was attended by Dirbinlitbang Puskesad, Colonel Ckm dr. I Made Mardika, Sp.PD who also opened this activity. 

"Early in 2022, we still hear news of the high Omicron variant of COVID-19 in Indonesia, Kalbe as a company that is engaged in the health industry will continue to be committed to fighting COVID-19 with various collaborations, one of which is by cooperating and collaborating with PUSKESAD," said Abi Nisaka , Kalbe's Manager of Corporate Sustainability. "United, working together, and collaborating are some of the solutions in overcoming COVID-19, because we cannot fight alone against COVID-19, which we have been dealing for nearly 3 years," he added.

Dirbinlitbang Puskesad Colonel Ckm dr. I Made Mardika, Sp.PD in his mandate at this activity said that the collaboration between PUSKESAD and Kalbe has been very closely intertwined and Kalbe has also provided a lot of assistance in the form of medicines and vitamins to maintain immunity in preventing COVID-19. He further conveyed, this health education is also an invitation to jointly maintain immunity and unite against the COVID-19 pandemic.

“The big uncertainty that we have to face until 2022 is COVID-19. The big contribution may be seen from the efforts made by the government and the private sector, but we can also make great efforts. By continuing to comply with health protocols and having vaccinated against COVID-19, we can take care of ourselves, our families, relatives, and others and stop the spread of COVID-19," said dr. Helmin Silalahi, Medical Senior Manager of Kalbe Consumer Health. “Maintaining an optimal immune system is also one of our efforts to fight COVID-19. Of course, by exercising, adjusting your diet, and taking vitamins, your immune system can be maintained. 4 selected herbal ingredients native to Indonesia (Sambiloto, Sembung, Red Ginger, and Meniran) in Fatigon Promuno can be an option that is close to the public because the ingredients are natural ingredients from Indonesia. It is also important for the content contained in Fatigon Promuno to have balanced properties, namely having sufficient immunostimulant and immunosuppressant benefits so that it is safe to consume for a long time and regularly," he added.

This form of collaboration was marked by the provision of assistance in the form of medicines from one of Kalbe's products, Fatigon Promuno which was symbolically handed by Abi Nisaka to the Dirbinlitbang Puskesad Colonel Ckm dr. I Made Mardika, Sp.PD at the Sasana Wira Sakti Hall, Mapuskesad, East Jakarta.

Kalbe at a glance
PT Kalbe Farma Tbk ("Kalbe") was established in 1966 and is one of the largest listed pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio: prescription medicines (Cefspan, Brainact, Broadced, etc.); health product division that handles over-the-counter medication (Promag, Mixagrip, Komix, Woods, Fatigon, etc.); multivitamins (Fatigon, H2, XonCe, Hevit-C, JossC1000, etc.);  as well as supplement and ready-to-consume drinks (Hydro Coco, Extra Joss); nutrition division (ChilKid, Prenagen, Diabetasol, Zee, etc,); and distribution & logistics division.
Kalbe has also developed EMOS, a digital service ecosystem for the community that is B2B; and KlikDokter that is a B2C service.  EMOS is an order management application system that makes it easy for distribution channels to manage stock or supply chains; while KlikDokter is a digital platform for health services, especially telemedicine that provides health consultations and health products needed by the community.
Kalbe currently has approximately 40 subsidiaries and 15 production facilities with international standard and employs approximately 16,000 employees dispersed across more than 76 branches throughout Indonesia. Since 1991, Kalbe is listed on the Indonesia Stock Exchange (IDX: KLBF).

Previous Article ACCELERATING COVID-19 VACCINATION IN SORONG – WEST PAPUA
Next Article TOGETHER MAKE THE NATION HEALTHY, KALBE SUPPORTS THE GOVERNMENT TO ACCELERATE THE COVID-19 VACCINATION AGES 6-11 YEARS OLD
Print
938 Rate this article:
No rating

Please login or register to post comments.

Name:
Email:
Subject:
Message:
x